Furthermore, emerging evidence indicates that gut bacteria-derived metabolites upregulate the production of pro-obesity adipokines, such as leptin, resistin, IL-6, MCP-1, and PAI-1, and downregulate the anti-obesity ones, such as adiponectin [60]. The gene discussed is CCL2; the disease is obesity disorder.